Scientific Advisory Board
The Scientific Advisory Board is comprised of experts in hematology, blood banking, transfusion medicine and anesthesiology. Advisors’ work experience includes the American Red Cross, Baxter, DuPont, i-STAT, and these medical centers: Cleveland Clinic, Duke University, New York University, University of North Carolina, University of Miami, University of Rochester and Virginia Commonwealth University.
Edwin A. Deitch, M.D. Dr. Deitch is Professor of Surgery at New Jersey Medical School, and served as Chair of the Department of Surgery at New Jersey Medical School from 1994-2011. Dr. Deitch has a long-standing interest in decreasing blood transfusions. In 1996 he began the University Center for Bloodless Surgery and Medicine at University Hospital in Newark, NJ, for which he serves as the Medical Director. He has been listed as one of the “Best Doctors in the US”, “Best Doctors in New Jersey” and “Best Doctors in New York” since 1999. Dr. Deitch has been recognized by his peers by election to the Presidencies of the Society of University Surgeons, the American Burn Association, the Shock Society and the Surgical Infection Society. Currently, Dr. Deitch is on the editorial board of nine professional journals.
As a researcher, Dr. Deitch has a history of continuous National of Institute of Health (NIH) funding since 1983. He has been the recipient of more than $19M in NIH funding in addition to industrial and Department of Defense grants. Dr. Deitch has published more than 300 original articles, edited three books, written 44 book chapters and 37 invited review articles. He has served as Visiting Professor at more than 78 Universities and Medical Schools, and has been an invited speaker at 104 conferences.
Michael P. Eaton, M.D. Dr. Eaton is the Denham S. Ward Professor and Chairman of the Department of Anesthesiology at the University of Rochester Medical Center, in Rochester, NY. Prior to being named Chairman, he served as Director of the Division of Cardiac Anesthesiology at the University of Rochester Medical Center. He is a member of the American Heart Association’s Council on Cardiovascular Surgery, and serves on the Board of Directors of the Society of Cardiovascular Anesthesiologists. He is an expert in the management of both adult and pediatric patients undergoing cardiac surgery, and in as expert in the use of hemostatic blood products and pharmaceutical agents during cardiac surgery.
Maureane R. Hoffman, M.D., Ph.D. Dr. Hoffman is tenured Professor of Pathology at Duke, and Director of the Hematology, Transfusion Service and Clinical Chemistry Laboratories at the Durham VA Medical Center. Dr. Hoffman’s research focuses on the role of cellular features in controlling hemostasis and thrombosis. Her work in collaboration with Dr. Harold Roberts and others has led to the development of an in-vitro cell-based model that mimics many aspects of hemostasis in-vivo. She has authored or co-authored over 115 journal articles, and has lectured extensively on the laboratory aspects of coagulation.
Mark Lifshitz, M.D. Dr. Lifshitz serves as Director of Clinical Laboratories at the New York University Medical Center. He is a leading expert on blood bank management and medical equipment, with four books and 14 book chapters published on these topics. His 80 published articles focus on medical equipment and devices, particularly blood analyzers.
Kandice Kottke-Marchant, M.D., Ph.D. Dr. Kottke-Marchant is Chair, Pathology and Laboratory Medicine Institute, Chair and Section Head of Hemostasis and Thrombosis in the Clinical Pathology Department at Cleveland Clinic, in Cleveland, Ohio. Dr. Kottke-Marchant has served as President of the International Society for Laboratory Hematology, a member of the Coagulation Resource Committee of the College of American Pathologists, and a member of the hematology testing committee of the American Board of Pathology. She is the author and co-author of over 250 articles, abstracts, and book chapters. She is the editor of the textbook An Algorithmic Approach to Hemostasis Testing.
Harold Ross Roberts, M.D. Dr. Roberts has been the Sarah Graham Kenan Professor of Medicine and Pathology, University of North Carolina (UNC), School of Medicine, since 1986. For 15 years he was chief of the Hematology Division of the UNC School of Medicine. He is a member of the editorial boards of Current Opinion in Hematology, Hematologic Pathology, and Bloodline Link. He has served, often as chairman, on a range of blue-ribbon committees and boards, both national and international, investigating new research and problems in coagulation. He is the author of over 270 articles and 170 abstracts on blood, coagulation, and related subjects.
Bruce Davis Spiess, M.D. Dr. Spiess is Professor with Tenure, Department of Anesthesiology, and Director of the Virginia Commonwealth University Reanimation Engineering Shock Center (VCURES). He has been a visiting professor lecturing on transfusion at Oxford University, Harvard, The Cleveland Clinic and The Mayo Clinic as well as many other major academic institutions. Dr. Spiess serves on the Joint Commission for Accreditation of Hospital Organizations (JCAHO) special task force on blood utilization, and has pioneered efforts to reduce unnecessary transfusions worldwide, and within Virginia Commonwealth University, where he is Chair of the Hospital-wide Blood Utilization Committee as well as the Operating Rooms Laboratories/Satellite Blood Bank.
Dr. Spiess has created and drives the blood transfusion reduction program (PET Program – Practicing Excellence in Transfusion) at VCU. Dr. Spiess has authored or co-authored over 200 scientific research publications and is the lead editor of Perioperative Transfusion Medicine, an authoritative textbook on blood usage in the perioperative period.
Benjamin Lichtiger, M.D., Ph.D., MBA (Emeritus Member) Dr. Lichtiger is Professor and Chair of the Department of Laboratory Medicine and Chief of the Section of Transfusion Medicine at MD Anderson Cancer Center. His area of expertise is Transfusion Medicine. In this area he is involved daily in direct patient care and serves as a consultant in issues related to transfusion medicine, appropriate utilization of blood components, blood component support for bone marrow transplantation and patients with hematologic malignant diseases, and support of peri-operative transfusion needs.
Dr. Lichtiger oversees and participates in the department’s two fellowship programs, Transfusion Medicine and Chemical Pathology. He also trains professionals from foreign countries in the latest blood banking techniques and managing approaches in transfusion medicine. Dr. Lichtiger is an active member on several institutional committees such as the Coordination of Care Subcommittee, Patient Safety Communication Task Force, Medical Practice Committee, and serves as Vice-Chair of the Transfusion Committee.
Dr. Lichtiger has also served on multiple committees of national and international organizations, including the Standards Subcommittee for Evaluation of International Variances, American Association of Blood Banks (AABB), the Standards Program Committee (AABB), the AABB’s Bacterial Contamination Standard Task Force, and the Professional and Technical Laboratory Advisory Committee of the Joint Commission for Accreditation of Hospitals, among others.